Clinical

Dataset Information

0

Gastrografin for Malignant Bowel Obstruction


ABSTRACT: Interventions: Treatment Arm will receive both: a. Standard palliative management of malignant bowel obstruction and b. One time oral dose of 100ml of sodium diatrozoate, meglumine datrozoate solution (Gastrografin) Primary outcome(s): Time from administration of gastrografin to resolution of malignant bowel obstruction signified by passage of flatus/stool.[30 minutes post intervention 6 hours post intervention 12 hours post intervention 24 hours post intervention 2 days post intervention 3 days post intervention] Study Design: Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Blinded (masking used);Assignment: Parallel;Type of endpoint: Safety/efficacy

DISEASE(S): Oral And Gastrointestinal-other Diseases Of The Mouth, Teeth, Oesophagus, Digestive System Including Liver And Colon,Cancer-bowel-small Bowel (duodenum And Ileum),Malignant Bowel Obstruction

PROVIDER: 2456399 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2526603 | ecrin-mdr-crc
2006-05-24 | GSE4715 | GEO
2012-11-01 | E-GEOD-36496 | biostudies-arrayexpress
| PRJNA1044566 | ENA
2012-11-01 | GSE36496 | GEO
2022-02-23 | PXD029244 | Pride
2021-10-08 | GSE185459 | GEO
| 2252631 | ecrin-mdr-crc
| PRJNA1044720 | ENA
| 2036413 | ecrin-mdr-crc